100 related articles for article (PubMed ID: 10757055)
1. cis-hydroxyproline stimulates the growth of rat mammary carcinoma cells.
Buck TB; Hall AL; Sinha CC; Bunce OR; Thorgeirsson UP
In Vivo; 2000; 14(1):7-11. PubMed ID: 10757055
[TBL] [Abstract][Full Text] [Related]
2. Sensitivity of N-nitrosomethylurea-induced rat mammary tumors to cis-hydroxyproline, an inhibitor of collagen production.
Lewko WM; Liotta LA; Wicha MS; Vonderhaar BK; Kidwell WR
Cancer Res; 1981 Jul; 41(7):2855-62. PubMed ID: 7018671
[TBL] [Abstract][Full Text] [Related]
3. Collagen-production inhibitors evaluated as antitumor agents.
Klohs WD; Steinkampf RW; Wicha MS; Mertus AE; Tunac JB; Leopold WR
J Natl Cancer Inst; 1985 Aug; 75(2):353-9. PubMed ID: 3860688
[TBL] [Abstract][Full Text] [Related]
4. Stimulatory effect of endogenous tissue inhibitor of metalloproteinases-1 (TIMP-1) overexpression on type IV collagen and laminin gene expression in rat mammary carcinoma cells.
Yoshiji H; Buck TB; Harris SR; Ritter LM; Lindsay CK; Thorgeirsson UP
Biochem Biophys Res Commun; 1998 Jun; 247(3):605-9. PubMed ID: 9647740
[TBL] [Abstract][Full Text] [Related]
5. Protease activity of urokinase and tumor progression in a syngeneic mammary cancer model.
Merchan JR; Tang J; Hu G; Lin Y; Mutter W; Tong C; Karumanchi SA; Russell SJ; Sukhatme VP
J Natl Cancer Inst; 2006 Jun; 98(11):756-64. PubMed ID: 16757700
[TBL] [Abstract][Full Text] [Related]
6. Human breast carcinoma desmoplasia is PDGF initiated.
Shao ZM; Nguyen M; Barsky SH
Oncogene; 2000 Sep; 19(38):4337-45. PubMed ID: 10980609
[TBL] [Abstract][Full Text] [Related]
7. Up-regulation of vascular endothelial growth factor by membrane-type 1 matrix metalloproteinase stimulates human glioma xenograft growth and angiogenesis.
Deryugina EI; Soroceanu L; Strongin AY
Cancer Res; 2002 Jan; 62(2):580-8. PubMed ID: 11809713
[TBL] [Abstract][Full Text] [Related]
8. Stromal cells promote angiogenesis and growth of human prostate tumors in a differential reactive stroma (DRS) xenograft model.
Tuxhorn JA; McAlhany SJ; Dang TD; Ayala GE; Rowley DR
Cancer Res; 2002 Jun; 62(11):3298-307. PubMed ID: 12036948
[TBL] [Abstract][Full Text] [Related]
9. Consequences of altered TGF-beta expression and responsiveness in breast cancer: evidence for autocrine and paracrine effects.
Tobin SW; Douville K; Benbow U; Brinckerhoff CE; Memoli VA; Arrick BA
Oncogene; 2002 Jan; 21(1):108-18. PubMed ID: 11791181
[TBL] [Abstract][Full Text] [Related]
10. Direct evidence of the importance of stromal urokinase plasminogen activator (uPA) in the growth of an experimental human breast cancer using a combined uPA gene-disrupted and immunodeficient xenograft model.
Frandsen TL; Holst-Hansen C; Nielsen BS; Christensen IJ; Nyengaard JR; Carmeliet P; Brünner N
Cancer Res; 2001 Jan; 61(2):532-7. PubMed ID: 11212246
[TBL] [Abstract][Full Text] [Related]
11. MT1-MMP is required for efficient tumor dissemination in experimental metastatic disease.
Szabova L; Chrysovergis K; Yamada SS; Holmbeck K
Oncogene; 2008 May; 27(23):3274-81. PubMed ID: 18071307
[TBL] [Abstract][Full Text] [Related]
12. Structural alterations within N-nitrosomethylurea-induced mammary tumors after in vivo treatment with cis-hydroxyproline.
Strum JM; Lewko WM; Kidwell WR
Lab Invest; 1981 Oct; 45(4):347-54. PubMed ID: 7300247
[TBL] [Abstract][Full Text] [Related]
13. Suppression of distant pulmonary metastasis of MDA-MB 435 human breast carcinoma established in mammary fat pads of nude mice by retroviral-mediated TIMP-2 gene transfer.
Lee YK; So IS; Lee SC; Lee JH; Lee CW; Kim WM; Park MK; Lee ST; Park DY; Shin DY; Park CU; Kim YS
J Gene Med; 2005 Feb; 7(2):145-57. PubMed ID: 15546163
[TBL] [Abstract][Full Text] [Related]
14. Anti-vascular endothelial growth factor receptor 2 antibody reduces tumorigenicity and metastasis in orthotopic prostate cancer xenografts via induction of endothelial cell apoptosis and reduction of endothelial cell matrix metalloproteinase type 9 production.
Sweeney P; Karashima T; Kim SJ; Kedar D; Mian B; Huang S; Baker C; Fan Z; Hicklin DJ; Pettaway CA; Dinney CP
Clin Cancer Res; 2002 Aug; 8(8):2714-24. PubMed ID: 12171905
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-24 induces expression of beta4 integrin but suppresses anchorage-independent growth of rat mammary tumor cells by a mechanism that is independent of beta4.
Xuan W; Li YJ; Liu G; Ben-David Y; Archer MC
Mol Cancer Res; 2009 Mar; 7(3):433-42. PubMed ID: 19258414
[TBL] [Abstract][Full Text] [Related]
16. 2-difluoromethylornithine and dehydroepiandrosterone inhibit mammary tumor progression but not mammary or prostate tumor initiation in C3(1)/SV40 T/t-antigen transgenic mice.
Green JE; Shibata MA; Shibata E; Moon RC; Anver MR; Kelloff G; Lubet R
Cancer Res; 2001 Oct; 61(20):7449-55. PubMed ID: 11606379
[TBL] [Abstract][Full Text] [Related]
17. A synthetic matrix metalloproteinase inhibitor decreases tumor burden and prolongs survival of mice bearing human ovarian carcinoma xenografts.
Davies B; Brown PD; East N; Crimmin MJ; Balkwill FR
Cancer Res; 1993 May; 53(9):2087-91. PubMed ID: 8347186
[TBL] [Abstract][Full Text] [Related]
18. Down-regulation of vascular endothelial growth factor by tissue inhibitor of metalloproteinase-2: effect on in vivo mammary tumor growth and angiogenesis.
Hajitou A; Sounni NE; Devy L; Grignet-Debrus C; Lewalle JM; Li H; Deroanne CF; Lu H; Colige A; Nusgens BV; Frankenne F; Maron A; Yeh P; Perricaudet M; Chang Y; Soria C; Calberg-Bacq CM; Foidart JM; Noël A
Cancer Res; 2001 Apr; 61(8):3450-7. PubMed ID: 11309307
[TBL] [Abstract][Full Text] [Related]
19. Effect of Smad7 expression on metastasis of mouse mammary carcinoma JygMC(A) cells.
Azuma H; Ehata S; Miyazaki H; Watabe T; Maruyama O; Imamura T; Sakamoto T; Kiyama S; Kiyama Y; Ubai T; Inamoto T; Takahara S; Itoh Y; Otsuki Y; Katsuoka Y; Miyazono K; Horie S
J Natl Cancer Inst; 2005 Dec; 97(23):1734-46. PubMed ID: 16333029
[TBL] [Abstract][Full Text] [Related]
20. Generation of cell types with myoepithelial and mesenchymal phenotypes during the conversion of rat mammary tumor epithelial stem cells into elongated cells.
Warburton MJ; Ferns SA; Hughes CM; Sear CH; Rudland PS
J Natl Cancer Inst; 1987 Jun; 78(6):1191-201. PubMed ID: 2438445
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
